COVID-19 in RheumatologyCOVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin AmericaElera-Fitzcarrald, Claudia MD∗; Ugarte-Gil, Manuel F. MD, MSc∗,†; Alarcón, Graciela S. MD, MPH‡,§Author Information From the ∗Facultad de Medicina, Universidad Científica del Sur †Servicio de Reumatología, Hospital Guillermo Almenara Irigoyen, EsSalud ‡Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Perú §School of Medicine, The University of Alabama at Birmingham, Birmingham, AL. All authors were involved in drafting or revising this article critically for important intellectual content, and all authors approved the final version to be published. The authors declare no conflict of interest. Correspondence: Claudia Elera-Fitzcarrald, MD, Universidad Cientifica del Sur. Av Panamericana Sur Km 19. Villa El Salvador 15067, Peru. E-mail: firstname.lastname@example.org. JCR: Journal of Clinical Rheumatology: September 2020 - Volume 26 - Issue 6 - p 215-217 doi: 10.1097/RHU.0000000000001493 Buy Metrics Abstract The COVID-19 (coronavirus disease 2019) pandemic has dramatically affected the entire world. Because of significant disparity levels in Latin American countries with deficient health care access and significant poverty, their population may end up among the most severely impacted. Patients with chronic conditions such as rheumatic diseases are quite vulnerable because of their high flaring risks and subsequent poor outcomes. Additionally, an overuse of antimalarials for the treatment of COVID-19 could lead to shortages in our region. Telemedicine, personal protective equipment use by patients and providers, web conferences, and comprehensive care are tools that will contribute to reduce the risk of infections and other complications in rheumatic disease patients, as well as to improve the knowledge and experience of rheumatologists at a global level. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.